2nd Quarter - Report
NVG, LLC for PHRMA
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Preserve Access to Affordable Generics Act (S. 214), Patent Quality Improvement Act of 2013 (S. 866), Patent Abuse Reduction Act of 2013 (S. 1013); General issues related to intellectual property and potential changes to the patent system
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREA LARUE | — |
Trade (domestic/foreign) TRD
General trade issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| IRENE BUENO | — |
| ANDREA LARUE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.